Clinical Trial Update: A Study to Evaluate Long-term Safety of Nintedanib in Children and Adolescents With Interstitial Lung Disease (InPedILD®-ON) [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the long-term safety of nintedanib in children and adolescents with interstitial lung disease has completed and results have been pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease

Drugs mentioned

• Nintedanib (Ofev) (Nintedanib)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Lung Diseases, Interstitial | Phase 3 | Status: COMPLETED | Results posted: 2026-03-04